» Articles » PMID: 30175230

Biomedical Informatics Applications for Precision Management of Neurodegenerative Diseases

Overview
Date 2018 Sep 4
PMID 30175230
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Modern medicine is in the midst of a revolution driven by "big data," rapidly advancing computing power, and broader integration of technology into healthcare. Highly detailed and individualized profiles of both health and disease states are now possible, including biomarkers, genomic profiles, cognitive and behavioral phenotypes, high-frequency assessments, and medical imaging. Although these data are incredibly complex, they can potentially be used to understand multi-determinant causal relationships, elucidate modifiable factors, and ultimately customize treatments based on individual parameters. Especially for neurodegenerative diseases, where an effective therapeutic agent has yet to be discovered, there remains a critical need for an interdisciplinary perspective on data and information management due to the number of unanswered questions. Biomedical informatics is a multidisciplinary field that falls at the intersection of information technology, computer and data science, engineering, and healthcare that will be instrumental for uncovering novel insights into neurodegenerative disease research, including both causal relationships and therapeutic targets and maximizing the utility of both clinical and research data. The present study aims to provide a brief overview of biomedical informatics and how clinical data applications such as clinical decision support tools can be developed to derive new knowledge from the wealth of available data to advance clinical care and scientific research of neurodegenerative diseases in the era of precision medicine.

Citing Articles

A novel muscle network approach for objective assessment and profiling of bulbar involvement in ALS.

Rong P, Heidrick L, Pattee G Front Neurosci. 2025; 18:1491997.

PMID: 39867453 PMC: 11759300. DOI: 10.3389/fnins.2024.1491997.


ADSS: A Composite Score to Detect Disease Progression in Alzheimer's Disease.

Shan G, Lu X, Li Z, Caldwell J, Bernick C, Cummings J J Alzheimers Dis Rep. 2024; 8(1):307-316.

PMID: 38405343 PMC: 10894615. DOI: 10.3233/ADR-230043.


Effects of dose change on the success of clinical trials.

Shan G, Ritter A, Miller J, Bernick C Contemp Clin Trials Commun. 2022; 30:100988.

PMID: 36117568 PMC: 9478360. DOI: 10.1016/j.conctc.2022.100988.


Influential Usage of Big Data and Artificial Intelligence in Healthcare.

Yang Y, Islam S, Noor A, Khan S, Afsar W, Nazir S Comput Math Methods Med. 2021; 2021:5812499.

PMID: 34527076 PMC: 8437645. DOI: 10.1155/2021/5812499.


Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning.

Pontoriero A, Nordio G, Easmin R, Giacomel A, Santangelo B, Jahuar S Comput Methods Programs Biomed. 2021; 208:106239.

PMID: 34289438 PMC: 8404039. DOI: 10.1016/j.cmpb.2021.106239.


References
1.
Alonso Vilatela M, Lopez-Lopez M, Yescas-Gomez P . Genetics of Alzheimer's disease. Arch Med Res. 2012; 43(8):622-31. DOI: 10.1016/j.arcmed.2012.10.017. View

2.
Oxtoby N, Garbarino S, Firth N, Warren J, Schott J, Alexander D . Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer's Disease. Front Neurol. 2017; 8:580. PMC: 5681907. DOI: 10.3389/fneur.2017.00580. View

3.
Mattsson N, Zetterberg H . Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications. Biomark Med. 2010; 3(6):735-7. DOI: 10.2217/bmm.09.65. View

4.
Guerreiro R, Ross O, Kun-Rodrigues C, Hernandez D, Orme T, Eicher J . Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol. 2017; 17(1):64-74. PMC: 5805394. DOI: 10.1016/S1474-4422(17)30400-3. View

5.
Lista S, Molinuevo J, Cavedo E, Rami L, Amouyel P, Teipel S . Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. J Alzheimers Dis. 2015; 48 Suppl 1:S171-91. DOI: 10.3233/JAD-150202. View